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Introduction 
The naturally occuring ergot alkaloids of the fungus, 
Claviceps purpurea, and their many derivatives have been of 
neuropharmacological interest for many years because of their 
ability to affect peripheral and central adrenergic and 
serotonergic systems. More recently, selected compounds 
such as lergotrile (2-chloro-6-methyl ergoline-8-beta-
acetonitrile) and bromocryptine (2-bromo-alpha-ergocryptine), 
have been given additional attention due to their possible 
therapeutic potential in the treatment of parkinson's 
disease, acromegaly and other disorders. There have been 
considerable data published attempting to establish the 
mechanism(s) whereby the ergot compounds exert their effects. 
A large portion of these experiments involves the inter-
action of ergot compounds with dopaminergic systems. This 
is a logical course of study, since many of the actions of 
the ergot compounds mimic the actions of compounds known to 
affect dopaminergic neurons, e.g. antagonists such as the 
1 
phencthieczines and butyrophenone" .. and agonists such as 
levodopa and apomorphine. In the last decade, much 
attention also has been focused on the r•ole of serotonin 
(5-hydroxytryptamine) in the mediation of dopaminergic 
systems. There have been many confl:tcting reports pub-
lished as to the role of serotonin but it is still uncer-
tain whether or not serotonin does indeed play a role. The 
present study investigates two dopaminergic effects of the 
standard dopamine agonist aporr.orphine and the ergoline 
lergotrile and the similarities or differences that 
exist when serotonergic fur.ctl':lr is a2.tered. 
Literature Survey 
1. Hypothermic action of apomorp~ine 
? 
An effect of apomorphine en rodent thermoregulator•y 
fur.ction <las first descr·:Lbed by Lapin and Samsono7a (1968a, 
~968b l. The first convincing evidence that linked drugs 
which stimulate dopamine receptors wi.th a decrease in core 
temperature. in rats and mice was presented in 1972 (Kruk, 
l972; J'i'uxe and Sjoqvist, 1972). Since that time, apomor-
ph:l-:ne has been cons:t.stently reported to cause a dose-related 
hypothermia .. in rats and mice using a variety of injection 
techniques (Barnett et al., 1972; Chie1 et al., 1974; Ary 
et al., ~977; Cox and Lee, 1978). Kruk (1972) found that 
dopamine, amphetamine and apomorphine injected intracerebro-
ventricularly into rats, ca.us.ed a fall in core temperature 
accompanied by a rise :tn s.k:tn tempe.rature. A maximum d::'op 
of about one degree centigrade was oht<erved with all three 
drugs, this effect be.ing completely antagonized by the 
specific dopamine antagonist pimozide. Fuxe and Sjoqvist 
(1972) obtained a drop of 3° to 4° C in the body temperature 
of mice administered apomorphine by intraperitoneal inject-
ion, and this effect was blocked by a dose of haloperidol 
that had no effect on body temperature itself. The nor-
adrenaline antagonist phenoxybenzamine and the anticholiner-
3 
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of apomorphine, thereby precluding alpha adrenergic or 
muscarini.c cholinergic mechanisms of action for apomorphine. 
These observations suggest that the hypothermic action of 
apomorphine is exclusively mediated by dopamine receptors. 
The apparent mechanism of action of apomorphine at the 
dopamine receptor had been determined several years earlier 
by Ernst (1967} and Anden (19671. Apomorphine-induced 
effects were found to be independent of exogenous catechol-
ami.ne release, which is contrary to the action of amphet-
amine, which produced its action through the release of 
endogenous catecholamines. It was concluded that the action 
of apomorphine was that of a direct agonistic action on the 
receptor structure. Thus it appears that apomorphine 
induces hypothermia by a direct stimulation of dopamine 
receptors. 
It has. long been recognized that the preoptic anterior 
hypothalamus has an important thermoregulatory function in 
warm~blooded animals (Reid et al., 19681. Utilizing central 
microinjection techniques, it has been determined that the 
site of action of apomorphine (Cox and Lee, 19 78} and 
dopamine CQuock and Gale, 19741 is a well defined area of 
dopamine receptors in the preoptic anterior hypothalamus. 
This area was- found to lie sensitive to th_e antagonistic 
acti.on of haloperidol in both studies. 
Tolerance to the hypothermic action of apomorphine has 
been demonstrated. Daily intraperi.toneal injections of 
response of subsequent injections of apomorphine and other 
dopamine agonists (Chiel et al., 197 4 2 • It was suggested 
that tolerance to the hypothermic effects was due at least_ 
in part to a decrease in sensitivity of the dopamine recep-
tors involved. Tolerance to the hypothermic action of apo-
morphine has also been demonstrated to occur after chronic 
rostral hypothalamic injections CAry et al,, 1977), but 
repeated injections into the lateral ventricle fail to pro-
duce tolerance . Therefore, the possibility of two different 
types- of dopamine receptors at two different sites has been 
suggested those surrounding the lateral ventricles being 
resistant to tolerance, 
2, Apomorphine-Induced Stereotypic Behavior 
4 
It has been known for over one hundred years. that apo-
morphine, administered by a variety of routes, produces a 
behavioral syndrome i.n rats consisting of continuous, pur-
poseless, compulsive acti.ons (Harnack, 18741. At threshold 
doses, an increase in exploratory activi.ty coupled with dis-
continuous sniffing is manifested. With increased dosage, 
normal activities s.uch. as grooming and feeding are extin-
guished and replaced with continuous sniffing, accompanied 
by small, repetitive head movements. High doses of apomor-
phine elicit a continuous gnawing, biting and licking 
response and the rat restricts its locomotion to a very 
small area. The nature of this behavior jus·tifies the term 
''stereotypy, 11 which has been applied to it (DiChiara and 
5 
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including rodents, cats, dogs, rabbits, pigeons and others 
(Randrup and Munkvad, l967; DiChiara and Gessa, 1978). 
Such stereotyped behavior in rodents can be quantified 
according to the dose-related appearance of one or more of 
the behavioral components (Ernst, l967; Costall and Naylor, 
1972l. Such scoring scales rate smiffing behavior (with 
locomotion) lowest while rating continuous gnawing (with 
little or no locomotion) the highest. Details of one such 
scoring system are shown in Table I. The appearance of the 
sniffing at low doses and gnawing at higher doses appears to 
be directly correlated with the appearance of apomorphine 
in brain tissue following peripheral injection (Butterworth 
and Barbeau, l975l. Other scoring systems exist for apornor-
phine-induced stereotypy, e,g. "gnaw compulsion" syndrome 
was considered to be. present (Ernst, l969) when rats gnaw 
at the wire mesh on the bottom of the cage for at least half 
a minute and, when loosened from the wire, start gnawing 
again. Others have used a quantal approach to determine the 
pre.s'ence of s·tereotyped behavior (Goetz and Klawans, 1974; 
~~~ -------------- ----- -
Table l -- Stereotyped behavior rating scale used in 
the present study 
0 = Rats exhibiting no stereotyped behavior; behavior 
is indistinguishable from that of control animals. 
1 = Rats exhibiting periodic sniffing and repetitive 
head and limb movements. 
_______ 2~-=-'---Rat_S_e.xhi_b_it_ing_c_ont_inuo_us_snif'f'ing_and_r_e_p_e_t_it_iye, ______ _ 
head and limb movements; exploratory activity is 
also present. 
3 = Rats exhibiting occasional licking, biting or 
gnawing; exploratory activity is also present. 
4 = Rats exhibiting persistent and intense licking, 
biting or gnawing; locomotion is restricted to 
a small area. 
5 = Rats exhibiting persistent and intense licking, 
biting or gnawing restricted to one location. 
6 
Jacobs, 1974)_, It has been observed that the presence of 
wooden shavings on the cage floor facilitates the gnawing 
component of stereotypy produced by intermediate doses of 
apomorphine, and that distracting stimuli, such as loud 
noise, inhibit this phenomenon (_DiCh.iara and Gessa, 1978)_. 
7 
Ernst (19672 concluded that apomorphine produces stereo-
typed behavior in rats by direct stimulation of the dopamine 
----~.L ·e-c-e~p-t-o-rs-1-o-c-a-t-e.-d-i-n-t--he-n-e-o-s-t-r-i--a-t-l::bu-. -~h-i-s-R-y-13-e-t-Re-s-i-s-i-s:------
supported by several other studies that have been reported. 
In the next three paragraphs these studies will be discussed. 
The ability of apomorphine to induce stereotyped behav-
ior has been shown to be abolished by lesions of the corpus 
striatum (Amsler, l923; Wolfarth et al., 1973). By stereo-
taxically implanting crystalline apomorphine or L-dopa into 
the brain of rats, Ernst and Smelik (1966) discovered that 
areas producing stereotype.d behavior were the dorsal part 
of the caudate nucleus and the globus pallidum. No stereo-
typed behavior was produced by implants into the ventral 
part of the caudate nucleus, in the region medial to the 
caudate nucleus (nucleus lateralis septi), in subthalamic 
structures, or in the substantia nigra. 
As noted earlier, evidence for the dlrect act ion of 
apomorphine on dopamine receptors 1'/as presented by Ernst 
09_672_ and Ande.n C19~67L 1-dopa, apomorphine and amphet-
amine all produce similar stereotyped behavior in rats. 
Depletion of brain amines by alpha-methyldopa failed to 
block_ apomorphine-induced stereotypy but profoundly antagon-
ized amphetamine-induced stereotypy, · Alpha-methyl tyro-
sine and res'erpine produce the same results. Fog C1967l 
demonstrated that intracerebral microinjections of dopamine 
into the corpus striatum restore amphetamine-induced stereo-
typy that has· been inhibited by alpha-methyl tyrosine. This 
strongly suggests that apomorphine does not act by dopamine 
J:'e.lease, but has a dopamine--like effect on th_e receptor 
8 
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of endogenous amines. Further evidence of this is the ob-· 
servation that monamine oxidase inhibitors can potentiate 
the behavioral effects of amphetamine (Ernst, 19671 and 1-. 
dopa but exert no effect on apomorphine-induced stereotyped 
behavior. Apomo:r"phine does have structural similarities to 
dopa, and it has been suggested that the presence of hydroxyl 
groups at the para- and meta- positions of the phenol ring 
in the phenol-ethylamine configuration is obligatory for a 
direct action on gnawing behavior (Ernst, 1967). Apomorphine 
poss·esses thi.s catechol configuration; amphetamine does not 
CFig. 12. 
Further suppo:r"t for the dopaminergic nature of apomor-
phine is that among neuroleptics, the most powerful antagon-
ists; of apomorphine are haloperidol, spiroperidol and pimo-
zide, These compounds are reported to be pure dopamine 
rece.ptor blockers at doses effective in antagonizing apomor-
phine-induced stereotyped behavior (DiChiara and Gessa, 1978). 
Jn contrast to the above widely accepted theories on 
apomo:r'phine acti.on, it has been shown that lesions of 
HO 
HO 
DOPAMINE 
APOMORPHINE 
9 
o-CH2fH-NH2 CH3 
AMPHETAMINE 
Figure 1 -- The structural relationships between dopamine, 
amphetamine, apomorphine and lergotrile. 
dopaminergic tracts or nerve cells are effective in abol-
ishing or decreasing apomorphine-induced stereotypy (Costall 
and Naylor, 1972)_. This would indicate that apomorphine-
induced stereotypy requires the presence of intact dopamin-
e.rgic terminals, and that apomorphine produces stereotypy 
via some presynaptic mechanism. Further evidence indicating 
a presynaptic action for apomorphine is that disruption of 
-----~L"'l-t-r-ane-l:l-r-e-n-a-l-a-m-i-ne-s-t-e-re~s-b.-y-e:X-y-})-e-r-t-i-ne-an-S.-RG-G-4-=-:l-2-B-4-------
(catecholamine depletors2 has been shown to reduce or 
a.bolish the stereotypic effects of apomorphine (Costall and 
Naylor, 1£73al. The electrolytic lesion techniques employed 
by Co stall and Naylor (1972, 1273b )_ have come under criti-
ci.sm recently by DiChiara and Gessa (19781. Their studies 
are in disagreement wi):;h data obtained by specific chemo-
lytic destruction of dopamine terminals with 6-hydroxy-
dopami.ne (Schoenfeld and Uretsky, ~9722_. Reasons suggested 
for this descrepancy include the incompleteness of the 
electrolytic lesions or interference with other non-dopamin-
ergic nerve tracts necessary for the expression of apomor-
phine-induced stereotypy. 
;Ei'urth.er evidence for the presynaptic activity of apo-
morphine, but not intrtnsically link.ed to s.tereotypy, is the 
ability of apomorphine to inhibit tyrosine hydroxylase, the 
enzyme responsible for converting tyrosine to dopa (Goldstein 
et al., 19_70}. It has been :proposed that a negative feed-
back mechani.sm exi.sts in dopaininergic neurons, and that the 
sttmulation of dopamine terminals by apomorphine activates 
this mechanism (Kehr et al., 1972 L Studies determining 
the rate of disappearance of dopamine after tyrosine hydroxy-
lase. inhibition with alpha-methyltyrosine have shown that 
apo:rnorphine consistently causes a decrease in the rate of 
disappearance of dopamine (Anden et al., 1967; Butcher and 
Anden, 1969).. Goldstein and colleagues (1970) found that 
apomorphine inh.ibited tyrosine hydroxylase as well as the 
------:&-y~B-t--fiB-a-i-s~e-f-ei-B-p-a-m-1-ne-f-re-m-t-y-r<:J-s-i-ae-i-B-s-t-r-:i..-a-t--a-l-s-l-i-e-e-s----.-------II!-R-e'-----
addition of haloperidol to the preparation did not affect 
the inhibitory effect of apomorphine. This experiment 
indi.cates that tbe inhibitory effectiveness. of apomorphine 
on striatal slices is not due to stimulation of dopamine 
receptors:, but due to a direct action on tyrosine hydroxy-
lase. The catech,el structure of apomorphine supports this 
theory. 
Costall and Naylor (12752 have attempted to differen-
tiate pharmacologi.cally and anatomically two components of 
stereotyped behavior, a low-intensity component (sniffing 
and repetitive move:rnentsl and a high-intensity component 
(_gnawi.ngL As :mentioned earlier, low dos.es of apomorphine 
cause sniffing and repetitive head and limb movements, where-
as high doses elici.t intensive gnawing. Intracerebral 
application of dopamine to the tuberculu:rn olfactoriu:rn and 
nucleus accumb.ens s.epti produces sniffing and movements 
characteristi.c of the low-intensity component. Lesions of 
these areas were effective in· ;reducing the stereotyped 
sniffing and head and li:rnb :movements induced by apomorphine. 
The substantia nigra and nucleus amygdaloideus centralis 
were determined to be the effectors for the high-intensity 
component using the same intracerebral application and 
lesion techniques-. It has become apparent from these 
findings- that other brain structures and pathways are also 
important in the expression of the stereotypic effects of 
apomorphine besides those of th_e neostriatum (Ernst and 
~2 
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and mesolimbic areas (tub_erculum olfactorium, nucleus amyg-
daloideus centralis and lateralis, nucleus accumbens septi) 
as well as those of the neos.triatum (caudate nucleus and 
putamen) all appear to have important functions in the full 
expression of apomorphine-induced stereotypic behavior. 
3. The Role of Serotonin in Thermal Regulation and Stereotypy 
There exists considerable evi.dence that serotonin plays 
a role in many central nervous system functions such as 
temperature regulation, neuroendocrine regulation, sleep, 
extrapyramidal function and behavior (Chase and Murphy, 1973). 
Recently it has been postulated that serotonin may have a 
function in regulating or mediating the central effects of 
dopaminomimetics such as apomorphine, Conflicting reports 
preclude the formulation of a single theory to explain the 
role that serot.onin ·may play in these systems 
Attempts to evaluate the role serotonin may play in the 
central nervous system or in the action of dopamine agonists 
may be grouped into four approaches. The first approach is 
biochemical, whereby attempts are made to increase or 
decreas.e brain serotonin. Systemically administered pre-
cursors of s·erotonin (L-tryptopban and 5-hydroxytryptophan) 
are believed to increas.e brain serotonin and neural trans-
mi.ssion, but evi.dence e:xists that this method may also inter-
fere with other catecholamines (Chase and Murphy, 1973) .. 
The opposi.te approach is to administer a drug that is 
believed to decrease brain serotonin and neural transmission, 
------'P a-J?-a-e-R-±-G-P-e-:F>R-e-R-y-l-a-1-a-B±-B-e-i-s-a-B-i-B-PL-i-B--i-t-e-r-e-f-t-rs-13-t-e-FJ-B.-a-B--------
hydroxylase and leads to a profound depletion of brain sero-
tonin (Koe and Weissman, .1966[. However, it has been shown 
that parachlorophenylalanine also lowers the levels of 
other brain amines including norepinephrine and dopamine 
l"ragliamonte et al., .1973 2.. 
A pharmacologic approach is to use selective blocking 
agents for serotonin receptors in the brain. Drugs such as 
cyproheptadine, cinanseri.n and methysergide are believed to 
block serotonin receptors directly. The major difficulty 
with. the.se pharmacologically based investigations is 
;finding a drug that acts exclusively on serotonin neurons. 
)?hysical techniques have been utilize.d for the in vitro 
study of serotonin function. Le.sions of the midbrain raphe 
are reported to deplete markedly the serotonin concentration 
of ;forebrain (Kostowski et al., 1968l, whereas electrical 
stimulation of this. area accelerates the synthesis and 
releas.e of serotonin (Kostowski et al., .1969}. As with 
pharmacological te.chniques, physical intervention is some-
what nonspecific and may a:('fect non-serotonergic nerve 
14 
fibers that tr.avers.e the raphe nucleus. (Chase and Murphy, 
1973 2. 
The fourth major approach to the study of serotonin 
Jl)echaniS1llS involves histofluorescent techniques. By 
meas:uring the brain leve.l$ of serotonin or 5-hydroxyindole-
acetic acid, its: principal deaminated metabolite, the steady 
state or turnover rate of serotonin can be monitored, and 
-----~tn-e-:re.-l-a-t-:i:-v-e-a-e-t-i~v-a-t-i-e-n-o-f-s-e-r-o-t:o-n--i-n-ne-u-re-n-s-e-a-n-b-e-e-s t ii~-~. -----
mated (Tozer et al,, l966L 
It has been reported that apomorphine increases sero-
toni.n turnover CScheel-Kruger and H.asselager, 1974; Grabow.-
ska, 1975; Maj, l975l. Apomorphine has been found to 
accelerate the disappearance of 5-hydroxyindoleacetic acid 
from the brain of pargyline -pretreated (a MAO inhibitor) 
rats as well as to facilitate the depletion of brain sero-
tonin caused by synthesis inhib.i ti.on (Grabowska, 1975). 
Depletion of brain serotonin was abolished when rats were 
treated with the dopamine antagoni.st, spiroperidol. Apo-
morphJne has been reported to increase brain serotonin and 
5-hydroxyindole.acetic acid levels, accelerate the disappear-
ance rate of serotonin after synthesis inhibition with 
· alpha-propyldopacetamide, and intensify serotonin fluor-
e,wense in raphe nuclei. CMaj, 19752. Dopami.ne blockers 
Cspi.roperi.dol and piJI)ozide t counteract these effects of 
apomorphine, and th.is has led to the suggestion that these 
agents influence serotonin neurons through. a secondary mech-
anis1!J, with the primary effects being directed at dopamine 
receptors. Further experi~ents have supported this theory. 
Apomorphine will increase the concentration of serotonin 
and 5~hydroxyindoleacetic acid in the raphe region in the 
mesencephalon of nor~al rats nut not in rats with a mesen-
cephalic-diencephal:l:c transection (Granowska et al., 1976). 
This tra.nsection interrupts the des·ce.nding pathway origin-
ating from dopamine structures of the forebrain. Transec-
tion alone was reported to cause no change in raphe serotonin 
or 5-hydroxyindolea.cetic acid, Therefore, it appears that 
apomorphine can activate serotonin neurons indirectly, This 
act:tvation of serotonergic neurons may be important in the· 
mediation of some of the pharmacological effects of apo-
morphine and other dopaminom:tmet:tcs. 
Serotonin a.ppears to also have a critical role in the 
complex network of neural factors which regulate body temp-
erature. Brain serotonin has been shown to increase in the 
ra.t during heat stress (Reid et al., 1968) and it has been 
propose.d that central serotonin pathways may be involved 
:tn the res·pons·e to heat stress in the rat. 
Seyeral s.tud:tes indicate that apomorphine-induced 
thermal effects have a serotonin link. Ni.dbrain raphe 
lesions have. been sh.own to attenuate the hypothermic effects 
of apomorphine in rats CClrabowska et al., 1974)_. Selective 
chemolytic des.·truction of serotonin neurons with 5, 6-di-
hydroxytryptamine, as well as serotonin depletion with para-
ch.lorophenylalanine, has been reported to strongly inhibit 
the hyperthermia induced by apomorphine. and other dopamine 
agonists· in rabbits (Carruba ·et al., 19:781. Intrahypo-
thala!l)ic pretreatment with. cyproh.eptadine or methysergide 
has b.een shown to block the h;ypothermic effect of dopamine 
agonists (Cox and Lee, 1979l. LSD (lysergic acid diethyl-
amide l will inhibit apomorphine-induced hypothermia and 
this effect is beli.eved to b.e due to stab.ilization of sero-
-
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strong evidence indi.cates that apomorphine and other 
dopaminomimetics may mediate thermal effects in mammals 
through a serotonergic link. 
While there i.s general agreement on a serotonergic 
link in apomorphine-induced hypothermia, apomorphine-induced 
stereotypy does not enjoy such. agreement. Studies have 
shown that an increase in brain serotonin induced by 5-
hydroxytryptophan or l-tryptophan or a reduction in brain 
serotonin with parachlorophenylalanine has no effect on 
apomorphine-i.nduced stereotypy (Rotrosen et al., 1972; 
Baldessarini et al., 19752.. The serotonin lesioning agents 
5,6- or 5,7-dihydroxytryptamine (Baldessarini et al., 19752 
and the serotonin antagonist methysergide (Rotroseri et al., 
~9:72 I have. also been reported to have no effect on apomor-
phine.-induced stereotypy. 
Certain reports i.ndicate that a decrease in serotonin 
concentration or a b.lockade of serotonin receptors can paten-
tiate apomorphine-induced stereotypy (Weiner et· al,, 1975; 
Jllolgilnicka et· al, 1 19.771, Treatments found to potentiate 
apomorphine~induce.d stere.otypy included parachlorophenyl-
alanine, cyproheptadine, methysergide and methergoline, 
The administrati.on of 5-hydroxytryptophan was found to 
inhib.it apomorphine-induced stereotypy (Weiner et al. ,1975). 
Consequently, it has- been suggested that s·erotonin plays an 
antagoni.s·tic role to that of dopamine in stereotyped behav~ 
ior (Molg1lnicka et al., 1977), In agreement with this, 
----~me-t--R-a-mi3h~e-t--a-m~ae-~-1-n8.-ue-e-El-$-t--er-e-e-t--y-J?y-ha-s-S-e-e-R-f8B-B-El-t-e-8-e------
inhibited by 1-tryptophan treatment and potentiated by 
parachlorophenylalanine treatment CBalsara. et al., 1979), 
In direct contrast to these findings, the serotonin 
agonist quipazine and the serotonin reuptake blocker ORG 6582 
have been reported to convert apomorphine-induced low-
intensity sniffing to high-intensity gnawing (Carter and 
Pycock, 1978), and cyproheptadine and metergoline have been 
reported to reduce apomorphine-induced stereotypy, In addit-
ion, parachlorophe.nylalanine, cinanserin and methysergide 
treatments have been reported to block :!:_-dopa- or :!:_-trypto-
phan-induced lateral head weaving and reciprocal forpaw 
treading in rats (_Jacobs, ~9742.. Dopamine synthesis inhibi-
tion wi.th alpha-methyltyrosine or receptor blockade with 
pimozide apparently had no effect on the stereotypy in 
these studies. Therefore, the role that serotonin may 
play in apomorphine-induced ste;r>eotyped behavior remains 
very· unclea;r>, 
4, Pharmacology of Lergotrile and Related Ergot Compounds 
The naturally occuring ergot alkaloids and the hundreds 
-
c 
of chemically related se.misynthetic agents that are now 
available have l'l.een described as a treasure chest of pharma-
cologically active and clinically useful compounds 
(Saameli, l976). Crude extracts of the parasitic fungus 
Claviceps purpure·a have been used for centuries as an 
oxytocic, but the cornerstone Of the pharmacology of ergot 
is· the classic work done by Sir Henry Dale early in the 
sal using ergot extracts in a spinal cat has been the basis 
for many studies in receptor pharmacology (for a review 
see Schild, 1976}. 
The influence of ergot compounds on noradrenergic 
synapses has been well studied. Dihydrogenated ergot alka-
loids. and ergotamine have been demonstrated to have direct 
venoconstrictor activity (Mellander and Nordenfelt, 1976). 
Aellig Cl976t and Chu and colleagues Cl976)~ have attributed 
part of this venoconstrictor activity to alpha-adrenoceptor 
stimulation. Other noradrenergic effects of ergot compounds 
have been dern.onstrated such as presynaptic noradrenaline 
release and the blocka.de of alpha-adrenoceptors (Salzmann 
and Pacha;_ l9.76l... Inhibition of catecholamine reuptake has 
been dern.onstrated with dihydroergotoxine in central nervous 
tissue ()vleier--Ruge and Iwangoff, l976)_. 
Recently, rn.uch attention has focused on the dopamin-
ergic activity of ergot compounds, probably due to the 
clinical application of ergot compounds in the treatment 
of such pathologies as parkinsonism, acromegaly, hyper-
prolactinemia-hypogonadism and puerperal lactation. The 
course of s·tudy on the dopaminergic agonist and antagonist 
activities of ergot derivatives and lergotrile have been 
explored in two different ways; 0) those which have employ-
ed biochemical and endocrinological techniques, and ( ii) 
th.ose whi.ch have used these compounds clinically as replace-
.ll)ents for traditional dopaminergic agents. 
--------s·everal stud-ies have demonstrated-"Ghe interact-ion or------
ergot derivatives and lergotrile with the dopamine receptor. 
After pretreatment with alpha-methyltyrosine, histochemical 
studies on neostriatal and limbic dopamine nerve terminals 
revealed a dose-dependent deceleration of dopamine fluor-
escence in rats treated with. ergocornine or bromocryptine 
lCorrodi et al., .l2.73 L. Lergotrile has also been reported 
to slow the decline in dopamine concentration after synthesis 
inhibiti.on with alpha-methyltyrosine along with being able 
to lower whole. brain DO).'AC l3, 4-dihydroyxphenylacetic acid) 
concentration i.n rats (;Fuller and ).'erry, .l9781, Lergotrile 
has been shown to cause a dose-dependant and haloperidol-
reversible depression of dopami.ne cell-firi.ng rates i.n the 
pars compacta o,f the rat substantia nigra (Walters et al,, 
.l979_L All of the.se ob.servations are consi.stent with the 
theory that ergol1nes and J ere;otri] e can act as di.rect 
dopamine agoni.sts 1.n: Vi.vo. 
In vi.t~o studi.es i.ndicate that bromocryptine and ler-
gotr:Ue have mixed putative agonist-antagonist activity on 
- -----
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dopamine re.ceptors., Re.ceptor b~inding studi.es. have shown 
that lergotrile has' a higher affinity for radiolabeled 
dopamine binding than bromocryptine, while bromocqrptine has 
a hi_gher affinity than lergotrile for radiolabeled haloper~ 
idol binding sites (Lew' et al., l9T7L Lergotrile has also 
been shown to antagonize the dopamine-stimulated adenyl 
cyclase activity in the striatum (Kebab ian et al. ,1977 L 
several categories of pharmacologically distinct dopamine 
receptors e.xist 0\eb.abian and Kebabian, 1978)_ and that ler-
. gotrile posses:se.s varying degrees of agonist-antagonist 
properties wi_th respect to these various receptors, 
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The role of hypothalamic dopamine in inhibiting pitui-
tary prolactin release provides a very good opportunity for 
studying the dopaminergic activity of a variety of compounds. 
Neuroleptics of many classes (butyrophenones, phenothiazines, 
thioxanthines 1 increas.e prolactin secretion in man in a 
dos:e"dependent manner without affecting plasma levels of 
other pituitary hormones (Langer and Sachar, l977L This 
response to neuroleptics is attributed to the blockade of 
dopamine in the. hypothalamic-pituitary axis, as dopamine 
completely antagonizes the response to the neuroleptics 
wh~en administered. Lergotrile has been shown to inhibit 
prolacti.n secretton in man and to attenuate the perphenazine-
induced sec;r>eti.on of prolactin (Lemberger et al., 127 4 )_. 
This effect was ver;r specific; no significant changes in 
the other pituitary hormones measured (GH, T3, T4, LH, FSH) 
-
c 
were observed, Many ergoline derivatives have been shmm to 
have the same effect (Clemens et al., l9741.. The mechanism 
of action for lergotrile in prolactin secretion inhib.ition 
hasc been suggested to be due to an activation of adena-
hypophyseal dopamine receptors (Clemens et al., l9 75). A 
major metaboli.te of lergotrile in humans, l3-hydroxy-lergo-
tri.le, has has been demonstrated to be a potent inhibitor 
21 
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Lergotrile has been shown to raise the levels of 
serum growth hormone in normal humans, but to lower the hor-
mone in acromegalic patients (Kleinberg et al., 1978; Thor-
ner et al. , 19 7 8l. Thorner and coworkers (19 7 8) have demon-
strated the dopaminergic nature of thi.s action by attenuat-
ing the response to lergotrile with. metoclopramide, a 
dopamine antagonist, Bromocryptine has also been demonstra-
ted to lower serum growth h.ormone in patients with acromeg-
aly (Thorner and Besser, 1976 ).. Both lergotrile and bromo-
cryptine show promi.se in the treatment of acromegaly. Clin-
ical improvement i.s seen as a decrease in sweati.ng, thinning 
of extremities, improvement in glucose tolerance and, of 
course, decrease in serum growth hormone levels. 
Both lergotrile and bromocryptine have been used sue"-. 
cessfully in the treatment of parkinsonism (Lieberman et al., 
1975; Goldstein $tal., l978; Klawana et al., 1978). Bind-
ing studi.es' to striatal membranes have demonstrated that the 
efficacy of these compounds in the treatment of parkinsonism 
can be attributed to the direct stimulation of dopamine 
receptors. (Goldste.in e.t al., 19}8 L One particularly 
interesting observation in all of these studies: is that 
lergotrile and bromocryptine were effective. in patients 
who were no longer responsive to L-dopa and carbidopa 
therapy. 
Certain ergot derivatives: have b.een demonstrated to 
induce stereotypy and/or hypoth.ermia in rodents. Lisuride 
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stereotypy and hypoth.ermia in mice (Horowski and Wachtel, 
~9761. Stereotypy was induced in control as well as 
reserpinized mice, indicating a direct dopaminergic action 
for this ergot derivative. A dose-response relationship 
has also been demonstrated for b.romocryptine-induced hypo-
th.ermia in rats (Calne and Claveria, 1975). It was suggest-
ed that the hypothermia produced was the result of bromo-
cryptine stimulating dopamine receptors in brain areas con-
trolling body temperature. 
Statement of the Problem 
Apomorphine and lergotrile induce hypothermia and 
stereotypy in the rat. It is generally accepted that these 
ef;fects are due to stimulation of dopamine receptors, as 
both effects can be completely antagonized by haloperidol 
or pimozide, Several studies have indicated that such 
central actions of dopaminomimeti.cs may be affected by sero-
tonergic mechanisms. 
Apomorphine.-induced hypothermia in rats appears to be 
mediate.d yia a serotonin link (!}rabowska: et al, ,1973; 
~-
Grabowska, l974; Cox and Lee, l9792, One study has in-
dicated that such a serotonin link may mediate apomorphine-
23 
induced hyperthermia in rabbits C:Quock and Horita, l97 4 2, 
While there are many studies examining the role of serotonin 
in apomorphine-induced temperature effects, there are very 
few studies that have examined the role of serotonin in 
the temperature effects induced by ergot derivatives. One 
-----:s-t-uGl-y--u-s-e-Gi-9-Feme-e-P~:f,_.S--±-ne-t-e-i-nEl-u-c-e-R-y-:fJe-r-t-R-e-P-m-i-a-i-R-r-ab-13-i-t-s:.,-----
and found this effect to be antagonized by treatment with 
either parachlorophenylalanine or 5,6-dihydroxytryptamine 
(Carruba et al,, l978 I, The role that serotonin may play 
in lergotrile-induced hypothermia has not been studied, 
The role that serotonin may play in apomorphine-
induced stereotypy i.s very unclear. This may be due in part 
to the difference in methods used to evaluate the behavior 
and in part to the absence of a specific agonist or antagon-
ist of serotonin, a problem that plagues many serotonin 
studies, Each of th.e. b.iochemical, pharmacologic and physical 
techniques used to facilitate or interrupt serotonergic 
activity may affect non-serotonergic nerve. activity as well 
(Chase and Murphy, 1973). 
Since both apomorphine and lergotrile produce similar 
effects which have been attributed to dopaminergic activity, 
the possibility exists that both compounds have a similar 
mechanism of acti.on. If this is true, i.t would be expected 
that any serotonergic influence on the effects of either drug 
would be the same, Th.e pres.ent study was undertaken to compare 
= 
'= 
two effe,cts induced by apomorphine ()1;ypothermia and 
stereotypy) with th,e corresponding effects induced by 
lergotrile and the changes that may arise in these responses 
when serotonin function is altered. The results of this 
study should provide some evidence as to whether apomor-
phine and lergotrile produce their effects through a 
common or parallel dopamine.rgic mechanism. 
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Materials and Methoda 
~. Animals 
Male Wis.tar rats (Simonsen Laboratories, Gilroy, Calif-
ornial, weighing between 150-250 g, were housed prior to 
experimentation in community cages on a standard light-dark 
?chedule. (;Light: 0.700-.1400} and given food (S/L Custom Lab 
Diet-G4. 5, Simonsen Labs}._ and water ad libitum. Ambient 
temperature was regulated at 22° ±. ~ ° C, ;For each. exper-
iment, naive animals were ch.osen at random, weighed and 
placed in individual cages. Food and water were withheld 
during the course of each experiment, 
2. Drugs 
Apomorphine hydrochloride CAPO, ~~erck and Co.), 
le.rgotrile mesylate (LER, Eli Lillyl, cyproheptadine hydro-
chloride CC¥P, Merck, Sharp and Dohme), cinanserin hydro-
chloride CCIN, Squibb, and Sons l., and parachlorophenyl-
alanine methyl ester hydrochloride (PCPA, Sigma) were all 
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pc~epared as aqueous solutions ir.-ll!lediately prior to use 
u~ing duoble-distilled water. Haloperidol (HAL, McNeil) 
was supplied i.n prepared Haldol R injection ampules and 
was diluted to final concentration with doub.le-distilled 
water, 
3. Procedure 
All experiments were started at 090.0 with drug and 
control pretreatments given by llOO. Double-distilled 
26. 
water served for control inj~_tions_._All inj_e_c_ti_on.s __ w_ere. ___ _ 
given intraperitoneally with pretreatment and challenge 
injections given on opposite sides of the peritoneal cavity. 
A constant injection volume of l.O ml/kg was used except for 
PCPA and its control, which were given at 2.0 ml/kg. All 
pretreatments were give-n 30 minutes prior to the challenge 
injections except for PCPA and its control, which were 
given 48 hours prior to challenge injections of APO or LER. 
All doses given refer to the salt of the compound except 
for HAL, where doses were given as the free base. The 
signi;f:J..cance of the drug effects were evaluated using the 
Student't :!:_test, Analysis of variance between the base~ 
line body- temperatures was evaluated us.ing Dunnett 't t test. 
4, Measurement of Body Temperature 
During experimentati.on, the animals were housed 
individually in metal cages (_24 ~ 30. ~ l5 em) on absorbant 
bedding i.n a controlled temperature room (22° ! l° C) after 
being weighed. The animals were allowed to acclimatize for 
60 minute.s prior to any temperature recording. An electron-
ic teleth.ermometer with a flexible rectal probe (Yellow 
Springs Instruments #43TA, probe #402} 1·;as used for all 
temperature measurements, and was inserted 5.0 em past 
the rectum (ins·ertion duration = 30 seconds 1. Baseline 
temperatures were taken every 15 minutes for at least one 
hour prior to any injection. Recordings were made 15 and 
30 minute.s: after pretreatment injections to assure that 
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:For APO experiments, recordings were made every 15 minutes 
for 20 minutes, and for LER, every 30 minutes for 300 
minutes -- this difference reflects the duration of action 
of each drug on body temperature. The change in body 
temperature was determined by subtracting each interval's 
reading from the baseline temperature for each animal. 
5. Measurement of Stereotypy 
The animals were housed in clear plexiglass cages 
(2') ~ 45 x l5 em) in a sUent, evenly lit room for 60 
minutes prior to the experiment. The floor of the cages 
was: filled with l-2 em of absorbant bedding (_KC Pharmacal) 
upon which the animals could gnaw or bite. This material 
was found to b.e very s.atisfactory to observe the gnawing/ 
biting component of stereotypy, Opaque screens were placed 
between individual cages to prevent behavioral interaction 
between animals., In all experiments, the animals were 
injected at staggered intervals of 2 minutes, and the 
intensity of stereotypy was assessed using a modified 
ye;rsion C'I'able ll of the s.cale developed by Costall and 
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Naylor (l972). A total stereotypy score was assigned to 
each animal consisting of the total of the 18 scores 
(taken every 5 minutes over the 90-minute observation 
period), although very often the duration of stereotypy 
was considerably less than 90 minutes. 
6. Determination of Brain Serotonin Content 
Determination of whole brain serotonin content was 
made by spectrofluorimetric assay by the method of Lai 
-----
and coworkers (l978l. Rats were killed by rapid decapita-
tion 48 hours after the double-distilled water or PCPA in-
jections. The entire brain was quickly removed, washed with 
tee cold 0.9 percent saline, weighed and homogenized for 4.0 
seconds (Brinkmann PCU-2 Polytron) in two volumes of cold 
0.3 N perchloric acid. Ths homogenate was centrifuged at 
2000 ~ g for lO minutes. Eight hundredfl of the supernate 
was: added to 2.0. ml Na 2HP0 4 buffer containing 0.1 M DEHPA 
(diethylhexyphosphoric acid) in 1.2 ml CHC1 3 . After shaking 
for two minutes, the organic layer was separated from the 
aqueous layer by centrifugation (600 ~ g for 5 minutes). One 
ml of the organic layer was removed and added to a test tube 
containing 2.0 ml heptane and 0.6 ml 0.2 N HCl and shaken 
for two minutes. Again the organic layer was separated from 
the aqueous layer by centrifugation (600 ~ g for 5 minutes). 
Two hundred pl of the aqueous layer was transferred to a 
test tube to which was added 100 pl o-phthalaldehyde 
reagent (50 mg percent in methanol). This mixture was 
vortexed immediately. Eight hundred pl concentrated HCl 
(12 NI was then added and vortexed immediately. The 
resulting mixture was heated in an 85° C water bath for 
30_ minutes', then cooled to room temperature (22° C 2 in 
29 
a water bath. The serotonin phosphor was read at an activa-
tion wavelength of 356 nm and a fluorescence wavelength 
of 480 .nm. Serotonin creatinine sulfate (50 pg/ml in 
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Results 
1. Hypothermia 
Apomorphine and lergotrile produced a dose-related 
hypothermia when injected intraperitoneally into rats (Fig. 
2,3). Pretreatment with haloperidol 0.5 mg/kg very highly 
significantly antagonized the maximum drop in body temper-
ature for both doses of apomorphine (Fig. 4,5) and all 
three doses of lergotrile (Fig. 6,7,8) without significantly 
affecting body temperature alone (Fig. 9). Pretreatment 
with cyproheptadine HCl 0.5 mg/kg had no significant effect 
on apomorphine-induced hypothermia (Fig. 4,5) but signifi-
cantly potentiated the hypothermic response of lergotrile 
(Fig. 6,7,82. Cyproheptadine HCl 0.5 mg/kg had no sig-
nificant effect on body temperature itself (Fig. 9). Pre-
treatment with cinanserin HCl 5.0 mg/kg very highly signifi-
cantly attenuated apomorphine-induced hypothermia (Fig. 10) 
while very highly significantly potentiating the hypothermic 
response of lergotrile (Fig. 11}. 
A single injection of parachlorophenylalanine methyl 
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Table II The effect of pretreatment (-30 minutes) with 
either haloperidol (HAL) or cyproheptadine HCl 
(CYP) on the body tempera~ure effects of 
intraperitoneal apomorphi~e HCl (APO). 
Mean body temperature °C + 1.0 SEM 
Time, APO 0.5 mg/kg 
min. (N=14) 
oa 36.83 + 0.15 
-
+15 36.44 + 0.16 
-
+30 36.32 + 0.15 
-
+45 36.46 + 0.13 
+60 36.59 + 0.14 
+75 36.73 + 0.15 
-
+90 36.76 + 0.17 
-
HAL 0 . 5 mg/kg 
followed by 
APO 0.5 mg/kg 
(N=8) 
36.73 + 0.18 
37.06 + 0.19 
-
36.95 + 0.18 
-
36.80 + 0.20 
-
36.81 + 0.20 
-
36.88 + 0.19 
-
36.89 + 0.18 
-
azero time values for the three treatment 
CYP 0 . 5 mg/kg 
followed by 
APO 0.5 mg/kg 
(N=lO) 
37.11 + 0 .11 
36.60 + 0.17 
-
36.54 + 0.22 
36.68 + 0.19 
-
36.75 + 0.18 
36.86 + 0.17 
-
36.88 + 0.13 
-
groups were 
checked for homogenity using Dunnett's t test, and no 
significant difference (P < 0. 05) was found (pooled 
s2=0,2494, d.f.=292. -
~ 
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Table III -- (Continued) 
Mean body temperature °C ~ 1.0 SEM 
Time, CIN 5.0 mg/kg 
min. followed by 
APO 2 . 0 mg/kg 
--------cN=n-) 
Q 36.66 + 0.21 
+15 36.21 + 0.31 
+30 36.13 + 0.31 
-
+45 36.27 + 0.30 
-
+60 36.50 + 0.26 
+75 36.63 + 0.20 
+90 36.73 + 0.17 
PCPA 300 mg/kg 
followed by 
APO 2 . 0 rng/kg 
(N=g-)-~ ~--
37.81 + 0.10 
36.74 ~ 0.27 
36.61 + 0.28 
36.73 + 0.26 
37.04 + 0.22 
37.36 + 0.11 
37.59 ~ 0 .09 
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Table IV -- The effect of pretreatment (-30 minutes) with 
either haloperidol (HAL) or cyproheptadine HCl 
(CYP) on the body temperature effects of 
intraperitoneal lergotrile mesylate (LER). 
Mean body temperature 0 c + 1.0 SEM 
Time, LER 0.3 mg/kg 
min. CN=9} 
oa 36.17 + 0.22 
+30 35.33 + 0.19 
-
+60. 35.31 + 0.20 
+90 35.64 + 0.23 
-
+120 35.98 + 0.24 
-
+150 36.17 + 0.23 
-
+180 36.27 + 0 .18 
+210 36.32 + 0.21 
+240 36.28 + 0.24 
+270 36.31 .:!:. 0 .~9 
+300 36.~9 + 0.16 
HAL 0 . 5 mg/kg 
followed by 
LER 0 . 3 mg/kg 
(N=8) 
36.98 + 0.26 
-
36.88 + 0. 23 
-
36.93 + 0.20 
-
36.94 .±_0.23 
36.80 + 0.24 
-
36.83 + 0.25 
-
36.98 + 0.20 
37.09 + 0.17 
-
37.01 + 0.17 
-
36.88 + 0. 20 
-
37.04 + 0.12 
-
a Zero time values for the three treatment 
CYP 0 . 5 mg/kg 
followed by 
LER 0.3 mg/kg 
(N=9) 
36.94 + 0.12 
35.93 .:!:. 0.19 
35.74 + 0.18 
36.00 + 0.12 
36.26 + 0.11 
36.51 + 0.16 
36.67 + 0.12 
36.76 + 0.09 
-
36.78 + 0.08 
-
36.89 + 0.09 
-
36.90 + 0.09 
-
groups were 
checked for homogenity using Dunnett's t test, and both 
the HAL and the CYp pretreated groups were significantly 
d;:rerent (r_ ( 0.:05) from the LER control group (pooled 
s -0.3660, d.f.-23). 
-
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Table V -- (Continued) 
Mean body temperature °C ~ 1.0 SEM 
Time, CIN 5.0 mg/kg PCPA 300 mg/kg 
min. followed by followed by 
LER 1.0 mg/kg LER 1.0 mg/kg 
--------'(N-=-1-G )------,(N-=-l-1-)----
oa 36.92 + 0.16 37.44 + 0.12 
+30 34.99 + 0.14 35.95 + 0.21 
+60 34.45 ~ 0. 23 35.28 + 0.28 
+90 34.63 + 0.24 35.45 + 0.24 
+120 35.47 ~ 0.31 35.65 + 0.22 
+150 36.18 ~ 0.31 36.14 + 0.21 8-o 
+180 36.88 + 0.26 36.65 + 0.19 ~ 
+210 36.92 + 0.19 37.05 + 0.14 
-
+240 36.84 ~ 0.17 37.25 + 0.08 
+270 36 .9l ~ 0.13 37.30 + 0.12 
"= 
+30,0 36.94 + 0.12 37.41 + 0.11 " 
b 
~ 
4~ 
Table VI The effect of pretreatment (-30 minutes) vrith 
either haloperidol (HAL) or cyproheptadine HCl 
(CYP) on the body temperature effects of 
intraperitoneal lergotrile mesylate (LER). 
Mean body temperature °C + 1.0 SEM 
Time, LER 3.0 mg/kg 
min. (N=10) 
oa 36.33 + 0.21 
+30 34.36 ±. 0.17 
+60 33.25 ±. 0.17 
+90 33.01 + 0.21 
+120 33.24 ±. 0. 23 
+150 33.68 + 0.28 
+180 34.01 ±. 0. 30 
+210 34.61 ±. 0. 31 
+240 35.01 ±. 0. 30 
+270 35.50 ±. 0.30 
+300 35.90 + 0.27 
-
HAL 0 . 5 mg/kg 
followed by 
LER 3 . 0 mg/kg 
(N=9) 
36.52 + 0.24 
34.96 ±. 0.32 
34.99 + 0.33 
-
35.48 + 0.34 
-
35.94 + 0. 33 
-
36.28 + 0.28 
-
36.49 + 0.21 
36.50 + 0.20 
36.59 + 0.20 
36.63 + 0. 21 
36.62 + 0.18 
-
CYP 0.5 mg/kg 
followed by 
LER 3 . 0 mg/kg 
(N=9) 
37.21 + 0.16 
35.18 + 0.24 
34.03 + 0.28 
33.71 ±. 0.25 
33.86 + 0.26 
34.11 ±. 0.25 
34.44 ±. 0.25 
34.98 ±. 0.29 
35.41 + 0.28 
35.78 ±. 0.25 
36.06 + 0.23 
azero time values for the three treatment groups were 
checked for homogenity using Dunnett 1 s ~ test, and only 
the C!P pretreated group was significantly different 
CP < 0. 05) from the LER control group (pooled s 2=o. 3914, 
d-:-f.=25) 
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ester HCl 300 mg/kg reduced ~hole brain serotonin content 
to 17 percent of water-pretreated control rats in ~8 hours 
(Table VII). Serotonin depletion with parachlorophenyl-
alanine apparently has no effect on apomorphine-induced 
hypothermia (Fig. 10) and may tend to potentiate lergotrile-. 
induced hypothermia (not statistically significant, see 
Fig. ll). 
2. Stereotyped behavior 
Apomorphine and lergotrile at low doses induced 
stereotypy consisting of increased locomotion coupled with 
sniffing and repetitive head and limb movements. At these 
doses, apomorphine produced continuous locomotor activity 
and head and limb movements while the locomotor activity 
and repetitive movements induced by lergotrile were discon-
tinuous, suggesting that apomorph~ne may stimulate the low- _ 
intensity components of stereotypy to a greater extent than 
lergotrile. Increasing the dose of apomorphine or lergo~· 
trile replaced locomotor activity with intermittent biting, 
gnawing or licking mouth movements. High doses of apomor-
phine or lergotrile evoked continuous (at least 30 seconds 
without stopping) biting, gnawing or licking mouth movements. 
Mouth movements induced by lergotrile mesylate 1.0 mg/kg 
were very continuous, frequently lasting several minutes 
without interruption. 
The results of haloperidol and cyproheptadine pretreat-
ments on apomorphine- and lergotrile-induced stereotypy are 
summarized in Table VIII. Haloperidol produced sl.ight sedation 
Table VII The effect of pretreatment (-48 hours) with 
either intraperitoneal double-distilled 
water (DH20) or parachlorophenylalanine 
methyl ester hydrochloride (PCPA) on the 
whole brain serotonin content of male rats. 
Treatment, dosage Mean + 1. 0 SEM t p 
DH20, 2.0 ml/kg 0.465 + 0.023 ug/g 
I N-=-6) 
PCPA, 
(N=6) 300 
mg/kg 0.081 + 0.017 ug/g 13.36 < 0.001 
59 
Table VIII -- The effect of pretreatment C-30 minutes) with e~ther haloperidol or 
cyproheptadine HCl on stereotyped behavior prodJced by intraperitoneal 
apomorphine HCl or lergotrile mesylate in male ~ats .. 
Treatment 
Control (H 20) 
Haloperidol 
Haloperidol 
Haloperidol 
Cyproheptadine HCl 
Cyproheptadine HCl 
Cyproheptadine HCl 
Total stereotypy score ± 1.0 SEM dN) 
mg/kg Apomorphine HCl 
0.5 mg/kg 
0.25 
0.5 
1.0 
0.5 
1.0 
2.0 
12.0 + 1.8 (13) 
2.7 + 0.5b (7) 
1.9 + l.lb (9) 
8.7±2.7(7) 
9.1 + 1.4 (10) 
I 
Apomorphine ROll 
2.0 mg/kg 
33.2 ± 3.1 (11\) 
2.0 + 0.4b (7) 
0.9 + 0.3b (9) 
26.3 ± 4.7 (lj) 
18.1 + 4.9a (~0) 
aSignificantly different from control ( P ( 0. 05) 
bvery highly significantly different from control (~ ( 0. 001) 
;11111111 llli:O I !'1.11 I I ' 'I' 
Lergotrile mesylate 
1.0 mg/kg 
24.2±2.7(15) 
5.3 ± l.lb (9) 
4.4 + l.2b (9) 
29.9 + 3.2 (10) 
35.6 + 3.4a (9) 
' I II":! l~ : I lll!frllll lll .. i.l .. : 1·11 
0\ 
0 
·nil 
and very highly significantly antagonized both apomorphine-
and lergotrile-induced stereotypy in a dose-related manner. 
Cyproheptadine also reduced the total stereotypy score pro-
duced by apomorphine in a dose-related manner. This antag-
onism became significant as the doses of apomorphine and 
cyproheptadine were raised. Cyproheptadine alone produced 
no behavioral effects. Cyproheptadine had an opposite 
------<e-:t'-f'ec-t-on-:teFgutr-1-J:-e=i:n-duced----stereotypy. A---significant 
potentiation of lergotrile-induced stereotypy was observed 
as the pretreatment dose of cyproheptadine HCl was increased 
to 2.0 mg/kg. 
Discussion 
The present study indicates that differences exist as 
to the effects of known serotonin antagonists (cyproheptadine 
and cinanserin) upon the hypothermic and stereotypic effects 
of apomorphine and lergotrile. Pretreatment with cyprohep-
tadine had no effect on apomorphine-induced hypothermia 
while it potentiated that of lergotrile, and pretreatment 
with cyproheptadine attenuated apomorphine-induced stereo-
typy while potentiating lergotrile-induced stereotypy. Pre-
treatment with cinanserin potentiated lergotrile-induced 
hypothermia while antagonizing apomorphine-induced hypotherm-
ia. This same pattern was observed with cinanserin in 
regard to apomorphine- and lergotrile-induced stereotypy. 
Despite the differences that serotonin blockade appears 
to have on apomorphine- and lergotrile-induced effects, the 
observed effects of these drugs are probably due to some 
effect on dopaminergic mechanisms. Convincing evidence in 
the rat exists linking the stimulation of dopamine receptors 
to hypothermia (Kruk, 1972; Fuxe and Sjoqvist, 1972) and 
62 
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stereotyped behavior (Ernst, 1967; Anden, 1967). The ability 
of the dopamine antagonist haloperidol to abolish the effects 
of both apomorphine and lergotrile in the present experi-
ments is presumptive evidence that both apomorphine and 
lergotrile exert their effects via dopamine receptors. This 
is in agreement with the consistent findings in rats that 
apomorphine induces hypothermia (Barnett et al., 1972; Chiel 
as stereotyped behavior (Harnack, 1874; Ernst, 1967; Costall 
and Naylor, 19722 and that dopamine antagonists can block 
the hypothermic and stereotypic effects of apomorphine (Kruk, 
1972; Fuxe and Sjoqvist, 1972; DiChiara and Gessa, 1978). 
Until the present investigation, lergotrile-induced hypother-
mia and stereotypy have not been studied and these effects 
have not previously been demonstrated to be attenuated 
by neuroleptics. However, inhibition of unit activity of 
dopamine cells by lergotrile has been reported to be antagon-
ized with haloperidol (Walters et al., 1979) and lergotrile 
has been found to compete with radiolabeled haloperidol 
binding sites in rat striatum (Lew et al., 1977). Addition-
ally, th.e hypothermic effect of another ergoline, bromo-
cryptine, has been demonstrated to be antagonized by pima-
zide (Calne et al., 1975). 
As both apomorphine and lergotrile appear to exert their 
hypothermic and stereotypic effects via dopamine receptors, 
the involvement of serotonin in these effects may be due to 
three different possibilities. First, serotonin may be a 
64 
physiological antagonist for the hypothermia and stereotyped 
behavior induced by dopaminergic stimulation, Serotonin 
could exert direct opposing action on the target response 
(hypothermia or stereotyped behavior) through an independent 
pathway or could inhibit the dopaminergic pathways leading 
to full expression of the target response. Second, serotonin 
may facilitate the effects of dopaminomimetics on hypothermia 
exist as a functional link in the final expression of dopam-
ine.rgic stimulation, or serotonin activation alone could pro-
duce an identical response to that of dopaminergic stimula-
tion. Third, serotonin may have no effect at all upon dop-
aminergic systems since neither cyproheptadine nor cinanserin 
can be classified as selective serotonin antagonists ( e.g. 
cyproheptadine is also a potent histamine antagonist; see 
Stone et al., 19732. 
The present findings suggest that serotonin antagonists 
attenuate apomorphine-induced hypothermia while facilitating 
lergotrile-induced hypothermia. This proposes a facilitatory 
role for serotonin in apomorphine-induced hypothermia and 
an antagonistic role for serotonin in lergotrile-induced 
hypothermia. The results with apomorphine in the present 
study are in agreement with the results of other investiga-
tors. Cox and Lee (1979) found that intrahypothalamic pre-
treatment with cyproheptadine or methysergide blocked apomor-
phine- or dopamine-induced hypothermia. They suggested that 
a serotonin link existed in dopamine-receptor-mediated hypo-
thermia in the rat. In one study (_Grabowska, 1974), 
lesions of midbrain raphe prevented apomorphine-induced 
hypothermia suggesting that the hypothermic action of apo-
morphine may be dependent upon activation of serotonin 
ne.urons originating in the midbrain. A serotonergic link 
has also been proposed in apomorphine-induced hyperthermia 
in the rabbit (Quock and Horita, 1976). The antagonism of 
cinanserin support the theory of a serotonin link mediating 
the thermal effects of apomorphine. 
If serotonin activation must occur for apomorphine to 
induce hypothermia in rats, it would be expected that 
serotonin activation alone should induce hypothermia in rats. 
Indeed, heat stress accelerates serotonin turnover in rat 
brain (Chase and Murphy, 1973). Additionally, administra-
tion of 5-hydroxytryptophan with a peripheral decarboxylase 
inhibitor produced hypothermia in rats (Grabowska et al., 
1973). This effect has also been demonstrated with trypto-
phan (Pawlowski, 1976), although cyproheptadine and methy-
sergide were shown to potentiate this effect -- an unexpected 
finding. It was suggested that cyproheptadine and methyser-
gide do not block the serotonin receptors for which stimula-
tion leads to hypothermia. This brings up the possibility 
of multiple receptors for both dopamine and serotonin in 
producing hypothermia in rats. Since the serotonin antagon-
ists, cyproheptadine and cinanserin, potentiated lergotrile-
induced hypothermia while having the opposite effect on 
66 
apomorphine-induced hypothermia, it is suggested that apo-
morphine and lergotrile may act through different but parallel 
dopaminergic pathways to produce hypothermia in the rat. 
A recent body of evidence exists which suggests that 
two or more distinct dopamine receptors exist. Two classes 
of dopamine receptors have been defined according to their 
association with, or independence from, dopamine-sensitive 
has been proposed that those receptors unassociated with 
adenyl cyclase be designated type alpha and those receptors 
associated with adenyl cyclase be designated type beta 
(Kebabian, 1978). Dopaminergic ergots such as lergotrile, 
lisuride, and bromocryptine and specific antagonists such as 
metoclopramide have been shown to be relatively specific for 
the alpha-dopaminergic receptor in the anterior pituitary, 
and fail to produce their effects upon the beta-dopaminergic 
receptor in the striatum. 
In view of the present findings, it appears that 
serotonin may have a facilitatory role on beta-dopaminergic 
receptor stimulation (by apomorphine) while antagonizing 
alpha-dopaminergic receptor stimulation (by lergotrile). The 
inability of parachlorophenylalanine to influence the change 
in body temperature induced by apomorphine or lergotrile in 
this study does not support this theory, but this lack of 
significant results may be due in part to the effect para-
chlorophenylalanine itself had on the body temperature (see 
Tables III and V}. 
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The modification of dopaminergic-induced stereotypy by 
antiserotonin agents has received extensive investigation, 
but lacks agreement. This may be due to differences in 
evaluating the stereotypic behavior(s), the vast number of 
chemically different serotonin antagonists used, and differ-
ences between species studied. Several studies have report-
ed the failure of serotonin agonists and antagonists to 
et a1., 1972; Baldessarini et al., 1975; Calil et al., 1978). 
The present study is in agreement \'lith another study that 
demonstrated reduction of apomorphine-induced stereotypy 
with the serotonin antagonists cyproheptadine and metergo-
line (Carter and Pycock, 1978). Still other studies report 
the potentiation of apomorphine-induced stereotypy by sera-
tonin antagonists, indicating an inhibitory role for seroto-
nin in this behavior (Weiner et al., 1975; Baldessarini and 
Griffith, 1976; Mogilnicka et al., 1977). These disagree-
ments preclude the assignment of a single role for serotonin 
in apomorphine-induced stereotypy. 
As with hypothermia, the antiserotonin effects on apo-
morphine-induced stereotypy were the opposite of the effects 
on lergotrile-induced stereotypy. This is a further indica-
tion that apomorphine and lergotrile do not stimulate iden-
tical dopaminergic pathways. This difference may involve 
the stimulation of adenyl cyclase-linked (beta type) dopamine 
receptors by apomorphine and stimulation of non-adenyl 
cyclase-linked (alpha type) dopamine receptors by lergotrile 
to produce stereotypy in the rat. Another possible explan-
ation is that apomorphine and lergotrile stimulate anatom-
ically different dopamine receptor populations with differ-
ing serotonergic influence. Costall and Naylor (1975) have 
suggested that the tuberculum olfactorium and nucleus 
accumbens septi are more important in the low-intensity 
components (locomotion, sniffing) of stereotypy while the 
the high-intensity (gnawing, licking) components. In the 
present study, it was noted that lergotrile produced more 
mouth movements and less locomotion than apomorphine over 
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the spectrum of doses used. Others have supported the stim-
ulation of anatomically different receptors by apomorphine 
and lergotrile (Tye et al., 1977; Gianutsos and Moore, 1980). 
Additionally, much attention has focused on the presynaptic 
activity of dopamine agonists (Costall and Naylor, 1973a, 
1973b; Silbergeld and Pfeiffer, 1977). Apomorphine has 
been reported to exert less presynaptic activity on dopamin-
ergic neurons than bromocryptine or lergotrile (Silbergeld 
and Pfeiffer, l977l. It is unknown what influence serotonin 
may have on the presynaptic events of dopamine neurons, but 
if serotonin influences dopamine nerve cell firing, pre-
synaptic actions of ergolines such as dopamine release or 
blockage of the reuptake of dopamine might be influenced by 
serotonergic manipulation. 
The results of this study indicate that the dopamine 
agonists apomorphine and lergotrile do not produce their 
-
~ 
similar effects through a common dopaminergic pathway. It 
may be possible that apomorphine and lergotrile activate 
two separate dopaminergic pathways, each with its own unique 
mode of serotonergic involvement. There is much evidence 
supporting this idea in the literature. Serotonin appears 
to play a facilitatory modulator role in the apomorphine-
activated pathway, while serotonin seems to play an inhibi-
-----~·-·-O-r-.1}-m-OdJJ.-l--a-t-G~I1G-±e-i-R-t--h-8-l-e-rgat-r-i-l-e---a-c-t-±-va-t-e-d-p-at-hway~=-----
both pathways leading to outwardly identical effects of 
hypothermia and stereotypy. 
:;I::t may be concluded from this investigation that (:!:.) 
more than a single dopaminergic pathlqay is involved in pro-
ducing hypothermia and stereotyped behavior in the rat; 
(ii} that these pathways are differentially affected by apo-
morphine and lergotrile; and (iii) that serotonin is intimate-
ly involved in both pathways, albeit in different manners. 
Conclusions 
The present study in male Wistar rats was designed to 
study the mechanisms of two effects (hypothermia and stereo-
typed behavior) induced by the dopamine agonists apomorphine 
and lergotrile. It is generally accepted that these effects 
are produced in rats through central stimulation of dopamine 
receptors; however, several studies have indicated that 
serotonergic mechanisms may mediate or modify these 11 dopam-
inergic 11 effects. 
The results of the present study demonstrate that differ-
ences exist as to the effects that known serotonin antagon~ 
ists (cyproheptadine and cinanserin) have upon the hypother-
mic and stereotypic effects of apomorphine and lergotrile. 
Pretreatment with cyproheptadine had no effect upon apomor-
phine-induced hypothermia while it potentiated that of lergo-
trile. Moreover, pretreatment with cyproheptadine attenuated 
apomorphine-induced stereotypy while potentiating lergotrile-
induced stereotypy, Pretreatment with cinanserin potentiated 
lergotrile-induced hypothermia and stereotypy while antagon-
70 
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izing both of these effects of apomorphine. 
Parachlorophenylalanine effectively reduced whole brain 
serotonin content in rats, but failed to produce any signifi-
cant change in the thermal response to apomorphine or lergo-
trile. 
Haloperidol was found to antagonize both the hypothermia 
and stereotypy produced by apomorphine or lergotrile. This 
The present findings suggest that serotonin plays a 
facilitatory modulator role in apomorphine-induced effects 
and that serotonin plays an inhibitory modulator role in 
lergotrile-induced effects. Recent studies by other investi-
gators have suggested that two or more pharmacologically 
and anatomically distinct types of dopamine receptors exist. 
It would appear that apomorphine and lergotrile may have the 
ability to selectively stimulate these different dopamine 
receptor populations. 
It may be concluded from this investigation that (~) 
more than a single dopaminergic pathway is involved in pro-
ducing hypothermia and stereotyped behavior in the rat; 
(ii l that these pathways are differentially affected by apo-
morphine and lergotrile; and (iii} that serotonin is intimate-
ly involved in both pathways, albeit in different manners. 
-
c 
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